According to classical models of drugreceptor interactions, competitive antagonists share with agonists the ability to bind to a common site on the receptor molecule. However, they are different from agonists, as they cannot trigger the "stimulus" that leads to biological responses-i.e., they lack intrinsic activity. For those receptors whose signals are transduced to effector systems by GTPbinding regulatory proteins (G proteins), a mechanistic equivalent of such a stimulus is an increased ability of agonist-bound receptor to accelerate nucleotide exchange and thus GTPase activity on the G-protein molecule. Here we show that for a member of this family of receptors (6 opioid receptors in membranes of NG108-15 neuroblastoma-glioma cells), two types of competitive antagonists can be distinguished. One type has no intrinsic activity, since it neither stimulates nor inhibits the GTPase activity of G proteins and its apparent ainmity for the receptor is not altered by pertussis toxin-mediated uncoupling of receptor and G protein. The second type, however, can inhibit GTPase and thus exhibits negative intrinsic activity; its affinity for receptors is increased following uncoupling from G proteins. The existence of antagonists with negative intrinsic activity may be a general feature of several classes of neurotransmitters or hormone receptors and calls for a reevaluation of biological effects produced by competitive antagonists.Although ,u and 8 opioid receptors can be clearly distinguished on a pharmacological basis (1), recent evidence (2, 3) indicates that these two types of receptors share the ability to interact with GTP-binding regulatory proteins (G proteins). In this respect, they belong to a large family of hormone and neurotransmitter receptors whose signals are transmitted to enzymes and ion channels across plasma membranes by intervening G proteins (reviews in refs. 4-6). Activation of one or more G proteins, which results in increase of GTPase activity, is the first detectable biochemical event that follows recognition of this group of receptors by agonists, regardless of the sort of signal that is actually propagated to effector molecules (5, 6). Receptor-mediated activation of G proteins involves the establishment of a ternary complex between ligand-occupied receptor and G protein, as suggested long before the isolation of G proteins. The findings (i) that guanine nucleotides exert negative heterotropic effects on the affinity of the receptor (7) only when the receptor is occupied by an agonist (8, 9), (ii) that a receptor prelabeled by agonists can be solubilized in a higher molecular weight form than when prelabeled by antagonists (10), and (iii) that agonists but not antagonists display complex binding isotherms in the absence of guanine nucleotides (11) liposomes (12, 13). Accordingly, the intrinsic activities of receptor ligands represent their ability to stabilize the ternary complex and range from null values for antagonists, which passively occupy the binding site, to various degrees of...